K

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Associate Director - Clinical Scientist

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeWaltham, MA, USA

About the Job

Requirements

  • At least 5 years of hands-on experience supporting clinical trials in a clinical development role.
  • Experience representing technical expertise on study teams and collaborating with colleagues to achieve milestones and goals.
  • Experience reviewing and interpreting clinical trial data listings.
  • Strong understanding of clinical trial conduct and cross-functional trial workflows.
  • Ability to work independently while navigating leadership demands by directing the broader study team in partnership with clinical operations.
  • Ability to manage multiple studies and deadlines in a fast-paced environment.
  • Ability to act as the subject matter expert for the cross-functional study team and contribute to development strategy as a member of a broader team.
  • Thorough understanding of the drug development process from IND/CTA through BLA/NDA submission.
  • Broad understanding of drug development functional areas, including preclinical, regulatory, pharmacovigilance, drug supply, data sciences (data management, biostatistics, programming), and clinical operations (site selection, study start-up, study conduct, and finalization).
  • Ability to understand, interpret, and communicate clinical information, including literature reviews, competitive intelligence, and changing treatment paradigms.
  • RN, MS, PhD, or PharmD, or equivalent clinical research experience.

Responsibilities

  • Support the Medical Directors for one or more Phase I–III clinical studies.
  • Lead studies across the full trial lifecycle, from start-up through database lock and reporting.
  • Provide scientific input to efficacy and safety endpoint objectives for clinical trials.
  • Identify and provide solutions to data trends, inconsistencies, and potential issues in partnership with Data Management, Biostatistics, and Safety.
  • Collaborate with cross-functional teams including Clinical Operations, Data Management, Biostatistics, Programming, Safety, and Regulatory.
  • Provide clinical oversight of study execution with cross-functional teams and ensure alignment with overall clinical strategy in partnership with the Clinical Science Lead for the program.
  • Author, review, and contribute to trial documents, including protocols, amendments, Investigator’s Brochures, and Clinical Study Reports.
  • Develop and deliver clear, well-structured presentations to study teams.
  • Understand and communicate the disease and treatment landscape to ensure scientific innovations are considered or incorporated into clinical trial development strategy.
  • Contribute to development and standardization of templates, processes, infrastructure, and procedures to support clinical development.
  • Travel as needed and attend site-related clinical development activities; form and maintain relationships with key opinion leaders.

Desired Qualifications

  • An advanced degree and/or professional certification or credentials are highly preferred.

About the Company

Kailera Therapeutics

Clinical-stage obesity and metabolic drugs developer

Kailera Therapeutics focuses on obesity and related metabolic conditions by acquiring and developing clinical-stage drug candidates and moving them toward commercialization. Its lead asset, KAI-9531, is an injectable dual agonist of GLP-1 and GIP receptors for obesity and type 2 diabetes, and the pipeline includes an oral GLP-1 agonist (KAI-7535), an oral tablet form of KAI-9531, and an injectable tri-agonist targeting GLP-1, GIP, and glucagon receptors (KAI-4729). The company differentiates itself by sourcing assets outside of early research, pursuing a mix of injectable and oral therapies, and leveraging a high-profile leadership team and substantial funding to progress a broad portfolio under external licenses. Kailera’s goal is to advance multiple metabolic disease therapies from clinical development toward commercialization to improve outcomes for patients with obesity and related conditions.

Company size
51-200
Company stage
IPO
Headquarters
Waltham, MA
Founded
2024

Recently Posted Jobs

Explore more opportunities at Kailera Therapeutics

See more jobs